{'fraction_non_alphanumeric': 0.02322841272513045, 'fraction_numerical': 0.0062279077596364245, 'mean_word_length': 4.900695134061569, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 1, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Transplant infectious disease: Renewing a home for TID research

In his editorial introducing the new Transplant Infectious Disease (TID) journal in June 2000, the founding editor Robert H. Rubin noted that “In both the exploration of space and the application of transplantation biology and science to the treatment of human disease, the emphasis is constantly onprogress – todomore, to push the envelope limitingwhat can be done. In both, attention to detail is an absolute requirement for success; in both, imagination and creativity are the cornerstones of progress."1 With this issue of the journal, we finalize the renewal of the journal as the home of TID research. When I started my career in TIDs, there were very few experts in the field – most centers had just a few TID experts to help with their complex patients. Over time, the field has blossomed and counts well over 800 TID experts globally. The expansion of those involved in the field has mirrored a significant growth of TID research. Diseases that once were the leading cause of morbidity and mortality after transplant now have multiple therapies and optimized diagnostics. None-the-less, we are still confronted with a myriad of infections where the best approach to diagnosis or treatment has yet to be defined. Through our collaborative efforts, we will find solutions for these problems. The TID journal continues to strive to be the home of TID research and clinical observations from the field globally, but now it has a fresh cover and renewed approach to sharing the advances we are bringing to the field. The TID journal was conceived and implemented by Bob Rubin in 1999, with the first edition published in March 2000. It remains the official journal of the TIDs Section of the Transplantation Society. Through the formative years, Dr. Rubin highlighted timely research, expert reviews, and focused special editions with guest editors. In 2011, Hans Hirsch and Francisco Marty became co-editors-in-chief of the Journal. Over their tenure, they focused on increasing publication of primary research in the field, expanded case reports, and increased the impact factor of the journal significantly. It is into the shoes of these TID giants that I have been asked to lead the Journal in its next phase. To reflect the renewal, we have a new cover that reflects our bright and vibrant field. I am grateful to Bob, Hans, and Francisco for their significant contribution to the field through the journal. While the journal is exceptionally strong, there is room to grow. The journal has historically been highly focused on adult solid organ transplantation. I hope to expand our offerings in hematopoietic stem cell transplantation and oncology ID research as well as grow our pediatric TID publications. We have engaged deputy editors to help expand our papers and readership in these key areas. We are looking to maintain the journal as a global home for the field and encourage submissions from every corner of the world that performs organ and hematopoietic stem cell transplantation. Learning from experts in the regions of endemic infectionwill help us take better care of our patients.We have specifically expanded our editorial board to best reflect the geographic diversity of our field.We encourage anyone at all transplant centers to engagewith the journal as an author or reviewer. While clinical cases have historically accounted for a large proportion of our submitted papers, we are changing our approach to cases. Cases will be considered only as brief letters termed clinical correspondences. We will only accept cases that have a key educational focus or highlight a truly novel pathogen, diagnostic strategy, or therapy. We will also select six exceptional cases to be the focus of a clinico-pathologic conference (CPC). The first two of these have been recorded (https://tts.org/component/tts/?view= presentation&id=201776&Itemid=134) and were exceptionally well received. The CPCs allow trainees and junior faculty to present interesting cases and then leverage global leaders in the field to summarize the state-of-the-art diagnostic and therapeutic approaches for the disease/diagnostic dilemma in question. These will be conducted first as a virtual webinar to engage a broad global audience and then will be written up into a formal publication. I think this will be an opportunity to expand the opportunities for challenging cases, engage a wider audience, and allow others to participate in the process using an interactive and novel approach. Nicole Theodoropoulos (@nikkitheomd) is the deputy editor in charge of the CPCs. This is a unique program in close collaboration with the TID Section, and Wanessa Clemente (@wan_clemente), Maricar Malanis (@maricar_malinis), and Stephanie Pouch (@StephaniePouch) are the liaisons for this program. We are also actively inviting leaders in the field to author editorials related to papers we are publishing as well as expert review articles. These expert review articles will be targeted at the TID audience and will attempt to dive deep into challenging topics that we all deal with. These, for example, will not be general reviews of Cytomegalovirus (CMV) for the transplant audience, but will be reviews that deeply review a focused topic, for example on managing resistant CMV. Monica Slavin is the deputy editor in charge of invited reviews. While we have identified some key topics for review, if you have ideas or want to write a focused review in your area of expertise, please reach out to Monica with an outline of your specific topic. In addition to our six annual issues, we are going to devote at least one additional special edition to an emerging focused topic. These will combine a series of invited review articles with new research papers. The first of these special editions will be guest edited by Graeme Forrest (@Gnfidz) and Shahid Husain (@shahidh80523771) and will focus